Quantum Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,220
Closed -$205K 249
2025
Q4
$205K Buy
+8,220
New +$207K 0.02% 216
2023
Q4
Sell
-9,555
Closed -$317K 129
2023
Q3
$317K Buy
9,555
+3,486
+57% +$123K 0.09% 74
2023
Q2
$223K Buy
6,069
+998
+20% +$38.8K 0.07% 89
2023
Q1
$207K Hold
5,071
0.07% 92
2022
Q4
$260K Buy
5,071
+2
+0% +$96 0.12% 65
2022
Q3
$222K Buy
5,069
+562
+12% +$27.3K 0.1% 71
2022
Q2
$225K Buy
+4,507
New +$230K 0.08% 84

Other funds holding PFE

Quantum Financial Advisors's PFE Position: Q1 2026 in Review

Quantum Financial Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 8,220 shares — an estimated $205K sold.

Quantum Financial Advisors first reported a position in PFE in Q2 2022 and held it in 7 quarters. The position peaked at $317K in Q3 2023. 2,953 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Quantum Financial Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Quantum Financial Advisors sold 8,220 Pfizer shares in Q1 2026, an estimated $205K.
  • Quantum Financial Advisors first reported a position in Pfizer in Q2 2022 and held it in 7 quarters.
  • Quantum Financial Advisors's Pfizer position peaked at $317K in Q3 2023.
  • 2,953 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Quantum Financial Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.